IP Library Assignment 030237/0588
Patent Assignment
Reel/Frame 030237/0588

Assignment of Assignor's Interest

Recorded: 2013-04-17 Pages: 9
Assignor
ABBOTT LABORATORIES
Executed: 2012-08-01
Assignee
ABBVIE INC.
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, ILLINOIS, 60064
Covered Properties (70)
Solid Pharmaceutical Dosage Formulations
Application: 11/939,640 →
Publication: US 2008/0181948
Benzimidazole Poly(Adp Ribose)Polymerase Inhibitors
Patent: 8,067,613 →
Application: 12/173,213 →
Publication: US 2009/0030016
Inhibitors of Protein Kinases
Patent: 8,110,572 →
Application: 12/174,334 →
Publication: US 2009/0054430
Amide Derivatives as TRPV1 Antagonists
Patent: 7,998,982 →
Application: 12/188,323 →
Publication: US 2009/0062345
Vitamin D Receptor Activators and Methods of Making
Patent: 8,377,913 →
Application: 12/205,998 →
Publication: US 2009/0131379
Octahydro-Pyrrolo[3,4-B]Pyrrole N-Oxides
Patent: 8,026,240 →
Application: 12/208,604 →
Publication: US 2009/0105267
Anti-Infective Agents and Uses Thereof
Patent: 8,178,548 →
Application: 12/212,315 →
Publication: US 2009/0176784
Anti-Infective Agents and Uses Thereof
Patent: 8,188,104 →
Application: 12/212,323 →
Publication: US 2009/0186912
Novel Compounds as Cannabinoid Receptor Ligands
Patent: 9,193,713 →
Application: 12/246,808 →
Publication: US 2009/0105306
2-{(R)-2-Methylpyrrolidin-2-Yl)-1H-Benzimidazole-4-Carboxamide Crystalline Form 1
Patent: 8,372,987 →
Application: 12/248,972 →
Publication: US 2009/0099245
2-{(R)-2-Methylpyrrolidin-2-Yl)-1H-Benzimidazole-4-Carboxamide Crystalline Form 2
Patent: 8,013,168 →
Application: 12/248,988 →
Publication: US 2009/0099246
Crystalline Chemotherapeutic
Patent: 7,947,843 →
Application: 12/251,879 →
Publication: US 2009/0118344
Crystalline Chemotherapeutic
Patent: 7,960,564 →
Application: 12/251,893 →
Publication: US 2009/0124815
Crystalline Form 2 of the Chemotherapeutic N-[4-(3-Amino-1H-Indazol-4-Yl)Phenyl]-N'-(2-Fluoro-5-Methylphenyl)Urea
Patent: 7,772,404 →
Application: 12/251,918 →
Publication: US 2009/0124816
Crystalline Chemotherapeutic
Patent: 7,994,208 →
Application: 12/251,949 →
Publication: US 2009/0105326
Crystalline Chemotherapeutic
Patent: 7,943,782 →
Application: 12/251,964 →
Publication: US 2009/0105486
Method for Reducing Side Effects of Cb-2 Receptor Agonist Therapy Using a Combination of a Selective Cb-2 Receptor Agonist and a Selective Cb-1 Receptor Antagonist
Patent: 8,044,071 →
Application: 12/252,811 →
Publication: US 2009/0105304
TRPV1 Antagonists
Patent: 8,084,616 →
Application: 12/256,924 →
Publication: US 2009/0124671
TRPV1 Antagonists
Patent: 7,998,993 →
Application: 12/256,931 →
Publication: US 2009/0124666
Method of Treating Arthritis
Application: 12/270,987 →
Publication: US 2009/0176785
Biaryl Substituted Azabicyclic Alkane Derivatives
Patent: 7,902,222 →
Application: 12/274,529 →
Publication: US 2009/0192186
Biaryl Substituted Diazabicycloalkane Derivatives
Application: 12/274,532 →
Publication: US 2009/0197860
Protein Kinase Inhibitors
Patent: 8,067,409 →
Application: 12/274,834 →
Publication: US 2009/0253723
Octahydropentalene Compounds as Chemokine Receptor Antagonists
Patent: 7,939,544 →
Application: 12/284,758 →
Publication: US 2009/0118298
Compositions and methods for crystallizing antibody fragments
Application: 12/322,088 →
Publication: US 2009/0202557
Benzothiazole and Benzooxazole Derivatives and Methods of Use
Patent: 8,153,813 →
Application: 12/337,433 →
Publication: US 2009/0163464
Thiazolylidine Urea and Amide Derivatives and Methods of Use Thereof
Patent: 8,383,657 →
Application: 12/338,849 →
Publication: US 2009/0163470
Compositions for Treatment of Cognitive Disorders
Application: 12/338,865 →
Publication: US 2009/0221648
TRPA1 Antagonists
Patent: 9,108,905 →
Application: 12/348,064 →
Publication: US 2009/0176883
TRPA1 Antagonists
Patent: 8,877,784 →
Application: 12/348,065 →
Publication: US 2009/0264480
Mammalian Expression Vectors and Uses Thereof
Patent: 8,187,836 →
Application: 12/354,568 →
Publication: US 2009/0239259
Extended Release Hydrocodone Acetaminophen and Related Methods and Uses Thereof
Patent: 9,226,907 →
Application: 12/365,639 →
Publication: US 2010/0010030
Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor
Application: 12/365,966 →
Publication: US 2009/0203709
Amide Derivatives as Positive Allosteric Modulators and Methods of Use Thereof
Patent: 8,536,221 →
Application: 12/367,096 →
Publication: US 2009/0270408
Thienopyrroles and Pyrrolothiazoles as New Therapeutic Agents
Patent: 8,101,645 →
Application: 12/378,308 →
Publication: US 2009/0209609
Methods for transforming yeast
Patent: 9,200,270 →
Application: 12/380,703 →
Publication: US 2009/0264320
Antibodies Against the Rgm a Protein and Uses Thereof
Patent: 8,962,803 →
Application: 12/389,927 →
Publication: US 2010/0028340
Tablets and Preparation Thereof
Application: 12/394,308 →
Publication: US 2010/0021540
Macrocyclic Spiro Pyrimidine Derivatives
Patent: 8,278,313 →
Application: 12/401,385 →
Publication: US 2009/0233904
Novel Compounds as Cannabinoid Receptor Ligands
Patent: 8,058,293 →
Application: 12/401,788 →
Publication: US 2009/0247500
Methods for Making Central Nervous System Agents That Are TRPV1 Antagonists
Patent: 8,232,411 →
Application: 12/407,857 →
Publication: US 2010/0016611
Anti-Viral Compounds
Patent: 8,232,246 →
Application: 12/495,299 →
Publication: US 2010/0168384
Prostaglandin E2 Binding Proteins and Uses Thereof
Patent: 8,624,002 →
Application: 12/499,646 →
Publication: US 2010/0040537
Prostaglandin E2 Dual Variable Domain Immunoglobulins and Uses Thereof
Patent: 8,822,645 →
Application: 12/499,652 →
Publication: US 2010/0074900
Methods of RNA Display
Patent: 8,916,504 →
Application: 12/570,931 →
Publication: US 2010/0105569
Antibodies That Bind to Il-12 and Methods of Purifying the Same
Application: 12/582,434 →
Publication: US 2010/0111853
Antibodies That Bind to Il-18 and Methods of Purifying the Same
Application: 12/582,469 →
Publication: US 2010/0150864
Isolation and Purification of Antibodies Using Protein a Affinity Chromatography
Patent: 8,895,709 →
Application: 12/582,506 →
Publication: US 2010/0135987
Viral Inactivation During Purification of Antibodies Cross Reference to Related Applications
Patent: 9,109,010 →
Application: 12/582,556 →
Publication: US 2010/0136025
Macrocyclic Hepatitis C Serine Protease Inhibitors
Patent: 8,420,596 →
Application: 12/584,716 →
Publication: US 2010/0144608
Stable Antibody Compositions and Methods of Stabilizing Same
Application: 12/625,057 →
Publication: US 2010/0172862
Abuse Resistant Melt Extruded Formulation Having Reduced Alcohol Interaction
Application: 12/631,010 →
Publication: US 2010/0172989
Anti-Infective Agents and Uses Thereof
Patent: 8,415,351 →
Application: 12/725,689 →
Publication: US 2011/0070193
Compounds as Cannabinoid Receptor Ligands
Patent: 8,492,371 →
Application: 12/732,421 →
Publication: US 2010/0249129
Tetrahydroisoquinolines, Pharmaceutical Compositions Containing Them, and Their Use in Therapy
Patent: 8,653,100 →
Application: 12/933,326 →
Publication: US 2011/0105502
Substituted Dihydropyrazolo[3,4-D]Pyrrolo[2,3-B]Pyridines and Methods of Use Thereof
Patent: 8,785,639 →
Application: 12/958,291 →
Publication: US 2011/0190489
Biaryl Substituted Azabicyclic Alkane Derivatives
Patent: 8,853,241 →
Application: 13/014,947 →
Publication: US 2011/0124676
Octahydropentalene Compounds as Chemokine Receptor Antagonists
Patent: 8,598,199 →
Application: 13/074,676 →
Publication: US 2011/0178096
Crystalline Chemotherapeutic
Patent: 8,486,988 →
Application: 13/088,869 →
Publication: US 2011/0196010
Novel Pyrazolo[3,4-D]Pyrimidine Compounds
Patent: 8,637,529 →
Application: 13/157,777 →
Publication: US 2012/0015963
The Compounds as Cannabinoid Receptor Ligands
Patent: 8,338,467 →
Application: 13/245,187 →
Publication: US 2012/0015929
Benzimidazole Poly(Adp Ribose)Polymerase Inhibitors
Application: 13/282,826 →
Publication: US 2012/0046303
TRPV1 Antagonists
Patent: 8,338,603 →
Application: 13/337,550 →
Publication: US 2012/0108642
Mammalian Expression Vectors and Uses Thereof
Patent: 8,455,219 →
Application: 13/368,618 →
Publication: US 2012/0237976
Benzothiazole and Benzooxazole Derivatives and Methods of Use
Patent: 8,580,968 →
Application: 13/410,206 →
Publication: US 2012/0164070
Anti-Infective Agents and Uses Thereof
Patent: 8,685,991 →
Application: 13/438,609 →
Publication: US 2012/0213733
Macrocyclic Hepatitis C Serine Protease Inhibitors
Patent: 8,642,538 →
Application: 13/439,551 →
Publication: US 2012/0196792
Anti-Infective Agents and Uses Thereof
Patent: 8,986,740 →
Application: 13/441,528 →
Publication: US 2012/0189580
Anti-Infective Agents and Uses Thereof
Patent: 8,501,238 →
Application: 13/451,889 →
Publication: US 2012/0244119
Treatment of Central Nervous System Disorders
Patent: 8,940,902 →
Application: 13/554,698 →
Publication: US 2013/0059829
Related Assignments (23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 9, 2008
From: BERNDL, GUNTHER; ROSENBERG, JOERG; LIEPOLD, BERND; FASTNACHT, KATJA
To: ABBOTT LABORATORIES
Reel/Frame 020775/0445 →
Assignment of Assignor's Interest Sep 8, 2008
From: VON GELDERN, THOMAS W.; BARKALOW, JUFANG H.; BARNES, DAVID M.; HAIGHT, ANTHONY R.
To: ABBOTT LABORATORIES
Reel/Frame 021493/0654 →
Assignment of Assignor's Interest Sep 23, 2008
From: GANDHI, VIRAJKUMAR B.; GIRANDA, VINCENT L.; GONG, JIANCHUN; PENNING, THOMAS D.
To: ABBOTT LABORATORIES
Reel/Frame 021569/0448 →
Assignment of Assignor's Interest Oct 10, 2008
From: ZHU, GUI-DONG
To: ABBOTT LABORATORIES
Reel/Frame 021664/0957 →
Assignment of Assignor's Interest Oct 27, 2008
From: DAI, YUJIA; JI, ZHIQIN; MICHAELIDES, MICHAEL R.
To: ABBOTT LABORATORIES
Reel/Frame 021739/0013 →
Assignment of Assignor's Interest Nov 12, 2008
From: VASUDEVAN, ANIL; BROWN, BRIAN S.; DAANEN, JEROME F.; GOMTSYAN, ARTHUR R.
To: ABBOTT LABORATORIES
Reel/Frame 021820/0587 →
Assignment of Assignor's Interest Nov 24, 2008
From: KOLACZKOWSKI, LAWRENCE
To: ABBOTT LABORATORIES
Reel/Frame 021882/0457 →
Assignment of Assignor's Interest Dec 16, 2008
From: HENRY, RODGER F.
To: ABBOTT LABORATORIES
Reel/Frame 021987/0479 →
Assignment of Assignor's Interest Dec 16, 2008
From: CARROLL, WILLIAM A.
To: ABBOTT LABORATORIES
Reel/Frame 021988/0546 →
Assignment of Assignor's Interest Dec 16, 2008
From: HENRY, RODGER F
To: ABBOTT LABORATORIES
Reel/Frame 021986/0302 →
Assignment of Assignor's Interest Dec 29, 2008
From: CARROLL, WILLIAM A.; DART, MICHAEL J.; PEREZ MEDRANO, ARTURO; NELSON, DEREK W.
To: ABBOTT LABORATORIES
Reel/Frame 022033/0849 →
Assignment of Assignor's Interest Jan 5, 2009
From: COWART, MARLON D.; MARSH, KENNAN C.; LIU, HUAQING; LEE, JAE Y.
To: ABBOTT LABORATORIES
Reel/Frame 022057/0727 →
Assignment of Assignor's Interest Jan 21, 2009
From: BORCHARDT, THOMAS B.
To: ABBOTT LABORATORIES
Reel/Frame 022131/0253 →
Assignment of Assignor's Interest Jan 26, 2009
From: BORCHARDT, THOMAS B.
To: ABBOTT LABORATORIES
Reel/Frame 022155/0233 →
Assignment of Assignor's Interest Jan 26, 2009
From: BORCHARDT, THOMAS B.
To: ABBOTT LABORATORIES
Reel/Frame 022153/0876 →
Assignment of Assignor's Interest Mar 3, 2009
From: FLENTGE, CHARLES A.; HUTCHINSON, DOUGLAS K.; BETEBENNER, DAVID A.; DEGOEY, DAVID A.
To: ABBOTT LABORATORIES
Reel/Frame 022337/0178 →
Assignment of Assignor's Interest Mar 4, 2009
From: DONNER, PAMELA L.; RANDOLPH, JOHN T.; KRUEGER, ALLAN C.; BETEBENNER, DAVID A.
To: ABBOTT LABORATORIES
Reel/Frame 022341/0629 →
Corrective Assignment to Correct the <Conveying Parties> Previously Recorded on Reel 021987 Frame 0479. Assignor(S) Hereby Confirms the Remove <Rodger F. Henry> Add <Michael J. Rozema>. May 7, 2010
From: ROZEMA, MICHAEL J.
To: ABBOTT LABORATORIES
Reel/Frame 024354/0155 →
Corrective Assignment to Correct the <Conveying Parties> Previously Recorded on Reel 021986 Frame 0302. Assignor(S) Hereby Confirms the Remove <Rodger F. Henry> Add <Thomas B. Borchardt>. May 18, 2010
From: BORCHARDT, THOMAS B.
To: ABBOTT LABORATORIES
Reel/Frame 024399/0557 →
Corrective Assignment to Correct the <Conveying Parties> Previously Recorded on Reel 022153 Frame 0876. Assignor(S) Hereby Confirms the Remove <Thomas B. Borchardt> Add <Michael J. Rozema>. May 18, 2010
From: ROZEMA, MICHAEL J.
To: ABBOTT LABORATORIES
Reel/Frame 024400/0347 →
Corrective Assignment to Correct the <Conveying Parties> Previously Recorded on Reel 022155 Frame 0233. Assignor(S) Hereby Confirms the Add <Alexander F. Chu-Kung>. Jul 22, 2010
From: CHU-KUNG, ALEXANDER F.; BORCHARDT, THOMAS B.
To: ABBOTT LABORATORIES
Reel/Frame 024725/0497 →
Corrective Assignment to Correct the <Conveying Parties> Previously Recorded on Reel 022131 Frame 0253. Assignor(S) Hereby Confirms the Add <Michael J. Rozema> and <Shailendra V. Bordawekar> and <Alexander F. Chu-Kung>.. Mar 22, 2011
From: BORCHARDT, THOMAS B.; ROZEMA, MICHAEL J.; BORDAWEKAR, SHAILENDRA V.; CHU-KUNG, ALEXANDER F.
To: ABBOTT LABORATORIES
Reel/Frame 025999/0133 →
Assignment of Assignor's Interest Aug 13, 2015
From: ZHAO, CHEN
To: ABBOTT LABORATORIES
Reel/Frame 036323/0483 →